ArticleMolecular diversity2023

Nanobody-peptide-conjugate (NPC) for passive immunotherapy against SARS-CoV-2 variants of concern (VoC): a prospective pan-coronavirus therapeutics.

Mamta Panda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.